系统性硬化症合并肺纤维化与肺气肿的总体死亡率
这项多中心回顾性研究纳入470例系统性硬化症(SSc)患者,按胸部CT分为SSc-CPFE、SSc-ILD、SSc-肺气肿和其他SSc四组,比较各组总体死亡率。SSc-CPFE患者男性更多、抗着丝点抗体阳性率更低、肺功能更差,Kaplan-Meier分析显示其生存率显著更差。
要点
- SSc-CPFE患者男性比例更高、抗着丝点抗体阳性率更低、肺功能更差。
- SSc-CPFE总体死亡率风险高于其他SSc亚型,尤其较其他SSc显著。
- 合并ILD的SSc患者应重视肺气肿的评估。
核心结论
- CPFE增加SSc患者的死亡风险,并伴随高度受损的肺功能。
研究设计与样本
- 多中心回顾性研究,纳入470例SSc患者(1959患者年),胸部CT由三名放射科医生盲法半定量评估,按CT表现分为SSc-CPFE、SSc-ILD、SSc-肺气肿和其他SSc四组。
主要发现
- 随访期间15.5%(73/470)患者死亡。
- 与SSc-ILD和其他SSc相比,SSc-CPFE患者男性更常见、抗着丝点抗体阳性率更低、肺功能更差(p<0.05)。
- Kaplan-Meier生存分析显示SSc-CPFE患者生存率显著更差,HR(vs SSc-ILD)为1.6(CI 0.5 to 5.2),(vs SSc-肺气肿)为1.6(CI 0.7 to 3.8),(vs 其他SSc)为2.8(CI 1.2 to 6.6)。
临床怎么用
- 在SSc合并ILD的患者中应评估肺气肿的存在,以识别死亡风险更高的CPFE亚型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This multicentre study aimed to investigate the overall mortality of combined pulmonary fibrosis and emphysema (CPFE) in systemic sclerosis (SSc) and to compare CPFE-SSc characteristics with those of other SSc subtypes (with interstitial lung disease-ILD, emphysema or neither). METHODS: Chest CTs, anamnestic data, immunological profile and pulmonary function tests of patients with SSc were retrospectively collected. Each chest CT underwent a semiquantitative assessment blindly performed by three radiologists. Patients were clustered in four groups: SSc-CPFE, SSc-ILD, SSc-emphysema and other-SSc (without ILD nor emphysema). The overall mortality of these groups was calculated by Kaplan-Meier method and compared with the stratified log-rank test; Kruskal-Wallis test, t-Student test and χ² test assessed the differences between groups. P<0.05 was considered statistically significant. RESULTS: We enrolled 470 patients (1959 patient-year); 15.5 % (73/470) died during the follow-up. Compared with the SSc-ILD and other-SSc, in SSc-CPFE there was a higher prevalence of males, lower anticentromere antibodies prevalence and a more reduced pulmonary function (p<0.05). The Kaplan-Meier survival analysis demonstrates a significantly worse survival in patients with SSc-CPFE (HR vs SSc-ILD, vs SSc-emphysema and vs other-SSc, respectively 1.6 (CI 0.5 to 5.2), 1.6 (CI 0.7 to 3.8) and 2.8 (CI 1.2 to 6.6). CONCLUSIONS: CPFE increases the mortality risk in SSc along with a highly impaired lung function. These findings strengthen the importance to take into account emphysema in patients with SSc with ILD.
引用
- Ariani A, Silva M, Bravi E, et al. Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open. 2019. PMID: 30886735. doi:10.1136/rmdopen-2018-000820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。